cytidine monophosphate has been researched along with Local Neoplasm Recurrence in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Blagden, SP; Gabra, H; Ghazaly, E; Gnanaranjan, C; Harrison, DJ; Kazmi, F; McCracken, NW; Nicum, S; Roux, RL; Spiers, L; Sukumaran, A | 1 |
| Arahata, M; Asakura, H; Nakao, S; Shimizu, Y | 1 |
| Horikoshi, A; Hosokawa, Y; Sawada, S; Takei, K | 1 |
2 trial(s) available for cytidine monophosphate and Local Neoplasm Recurrence
| Article | Year |
|---|---|
A Phase Ib Open-Label, Dose-Escalation Study of NUC-1031 in Combination with Carboplatin for Recurrent Ovarian Cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytidine Monophosphate; Disease-Free Survival; Drug Dosage Calculations; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Treatment Outcome | 2021 |
The value of oral cytarabine ocfosfate and etoposide in the treatment of refractory and elderly AML patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cytidine Monophosphate; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local | 2008 |
1 other study(ies) available for cytidine monophosphate and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Persistent molecular remission of refractory acute myeloid leukemia with inv(16)(p13.1q22) in an elderly patient induced by cytarabine ocfosfate hydrate.
Topics: Aged; Antineoplastic Agents; Arabinonucleotides; Chromosome Inversion; Chromosomes, Human, Pair 16; Cytidine Monophosphate; Female; Humans; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local; Remission Induction | 2015 |